Epigral surges on commissioning first Chlorotoluenes Value Chain facility in Gujarat
Epigral is currently trading at Rs. 1980.20, up by 52.55 points or 2.73% from its previous closing of Rs. 1927.65 on the BSE.
The scrip opened at Rs. 1927.65 and has touched a high and low of Rs. 2022.00 and Rs. 1915.25 respectively. So far 6255 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2408.35 on 03-Oct-2024 and a 52 week low of Rs. 1034.80 on 22-Mar-2024.
Last one week high and low of the scrip stood at Rs. 2022.00 and Rs. 1760.25 respectively. The current market cap of the company is Rs. 8597.42 crore.
The promoters holding in the company stood at 68.94%, while Institutions and Non-Institutions held 7.34% and 23.72% respectively.
Epigral has successfully commissioned India’s first Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on March 24, 2025. This facility will further strengthen the company’s integrated complex and will supply intermediates for pharmaceutical and agrochemical industries.
Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India.
